Richard Burr: “I think that, clearly, there will be a continuing debate in Washington around whether we fund agencies at an adequate…”

“I think that, clearly, there will be a continuing debate in Washington around whether we fund agencies at an adequate level. The reality is that agencies have the determination to decide where they put their funding, and in many cases it is our responsibility to make sure that we bring them back focused on their core mission. In the case of the FDA, it is on food safety, it is on the approval of pharmaceutical applications, and it is on the approval of medical devices. I think we enhance that likelihood with the passage of this bill.”